Petros D Grivas (Petros Grivas, P Grivas)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 57

Top Topics

African American

Circulating Tumor

Prostate Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO precision oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Targeted oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Petros D Grivas, Damien Pouessel, Chandler H Park, Philippe Barthelemy, Manojkumar Bupathi, Daniel P Petrylak, Archana M Agarwal, Sumati V Gupta, Aude Fléchon, Chethan Ramamurthy, Nancy B Davis, Alejandro Recio-Boiles, Cora N Sternberg, Astha Bhatia, Cabilia Pichardo, Mitch Sierecki, Julia Tonelli, Huafeng Zhou, Scott T Tagawa, Yohann Loriot
Sacituzumab Govitecan in Combination With Pembrolizumab for Patients With Metastatic Urothelial Cancer That Progressed After Platinum-Based Chemotherapy: TROPHY-U-01 Cohort 3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Ruben Raychaudhuri, George Mo, Abuzar Moradi Tuchayi, Laura S Graham, Roman Gulati, Colin C Pritchard, Michael C Haffner, Todd Yezefski, Jessica E Hawley, Heather H Cheng, Evan Y Yu, Petros D Grivas, Robert B Montgomery, Peter S Nelson, Delphine L Chen, Thomas A Hope, Amir Iravani, Michael Thomas Schweizer
Genomic Correlates of Prostate-Specific Membrane Antigen Expression and Response to 177 Lu-PSMA-617: A Retrospective Multicenter Cohort Study. JCO precision oncology 8 (2024)
Caitriona Cahir, Xin Victoria Wang, David M Hyman, Petros D Grivas, Edith P Mitchell, John J Wright, Elad Sharon, Robert C Gray, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Jue Wang, Kari B Wisinski, James V Tricoli, Barbara A Conley, Lyndsay N Harris, Carlos L Arteaga, Peter J O'Dwyer, Helen X Chen, Keith T Flaherty
Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Caitriona Cahir, Xin Victoria Wang, David M Hyman, Petros D Grivas, Edith P Mitchell, John J Wright, Elad Sharon, Robert C Gray, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Jue Wang, Kari B Wisinski, James V Tricoli, Barbara A Conley, Lyndsay N Harris, Carlos L Arteaga, Peter J O'Dwyer, Helen X Chen, Keith T Flaherty
Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Jacob B Leary, Thomas Enright, Dimitra Rafailia Bakaloudi, Alina Basnet, Gennady Bratslavsky, Joseph Jacob, Philippe E Spiess, Roger Li, Andrea Necchi, Ashish M Kamat, Dean C Pavlick, Natalie Danziger, Richard S P Huang, Douglas I Lin, Liang Cheng, Jeffrey Ross, Rafee Talukder, Petros D Grivas
Frequency and Nature of Genomic Alterations in ERBB2-Altered Urothelial Bladder Cancer. Targeted oncology 19 (3) (2024)
Caitriona Cahir, Xin Victoria Wang, David M Hyman, Petros D Grivas, Edith P Mitchell, John J Wright, Elad Sharon, Robert C Gray, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Jue Wang, Kari B Wisinski, James V Tricoli, Barbara A Conley, Lyndsay N Harris, Carlos L Arteaga, Peter J O'Dwyer, Helen X Chen, Keith T Flaherty
Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Caitriona Cahir, Xin Victoria Wang, David M Hyman, Petros D Grivas, Edith P Mitchell, John J Wright, Elad Sharon, Robert C Gray, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Jue Wang, Kari B Wisinski, James V Tricoli, Barbara A Conley, Lyndsay N Harris, Carlos L Arteaga, Peter J O'Dwyer, Helen X Chen, Keith T Flaherty
Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Caitriona Cahir, Xin Victoria Wang, David M Hyman, Petros D Grivas, Edith P Mitchell, John J Wright, Elad Sharon, Robert C Gray, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Jue Wang, Kari B Wisinski, James V Tricoli, Barbara A Conley, Lyndsay N Harris, Carlos L Arteaga, Peter J O'Dwyer, Helen X Chen, Keith T Flaherty
Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Jacob B Leary, Thomas Enright, Dimitra Rafailia Bakaloudi, Alina Basnet, Gennady Bratslavsky, Joseph Jacob, Philippe E Spiess, Roger Li, Andrea Necchi, Ashish M Kamat, Dean C Pavlick, Natalie Danziger, Richard S P Huang, Douglas I Lin, Liang Cheng, Jeffrey Ross, Rafee Talukder, Petros D Grivas
Frequency and Nature of Genomic Alterations in ERBB2-Altered Urothelial Bladder Cancer. Targeted oncology 19 (3) (2024)
Ruben Raychaudhuri, George Mo, Abuzar Moradi Tuchayi, Laura S Graham, Roman Gulati, Colin C Pritchard, Michael C Haffner, Todd Yezefski, Jessica E Hawley, Heather H Cheng, Evan Y Yu, Petros D Grivas, Robert B Montgomery, Peter S Nelson, Delphine L Chen, Thomas A Hope, Amir Iravani, Michael Thomas Schweizer
Genomic Correlates of Prostate-Specific Membrane Antigen Expression and Response to 177 Lu-PSMA-617: A Retrospective Multicenter Cohort Study. JCO precision oncology 8 (2024)
Petros D Grivas, Damien Pouessel, Chandler H Park, Philippe Barthelemy, Manojkumar Bupathi, Daniel P Petrylak, Archana M Agarwal, Sumati V Gupta, Aude Fléchon, Chethan Ramamurthy, Nancy B Davis, Alejandro Recio-Boiles, Cora N Sternberg, Astha Bhatia, Cabilia Pichardo, Mitch Sierecki, Julia Tonelli, Huafeng Zhou, Scott T Tagawa, Yohann Loriot
Sacituzumab Govitecan in Combination With Pembrolizumab for Patients With Metastatic Urothelial Cancer That Progressed After Platinum-Based Chemotherapy: TROPHY-U-01 Cohort 3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Antonio Cigliola, Alina Basnet, Joseph M Jacob, Chiara Mercinelli, Valentina Tateo, Damiano Alfio Patanè, Gennady Bratslavsky, Liang Cheng, Petros D Grivas, Ashish M Kamat, Philippe E Spiess, Dean C Pavlick, Douglas I Lin, Jeffery S Ross, Andrea Necchi
Urachal and Nonurachal Adenocarcinomas of the Urinary Bladder: A Comprehensive Genomic Profiling Study. JCO precision oncology 8 (2024)
Uttam Satyal, Henkel Valentine, David R Liu, Michael J Slifker, Costas D Lallas, Edouard J Trabulsi, Laura Bukavina, Lauren Szeto, Jean H Hoffman-Censits, Kent W Mouw, Bishoy Morris Faltas, Petros D Grivas, Ilsiya Ibragimova, Sima P Porten, Eliezer Van Allen, Daniel M Geynisman, Daniel C Parker, John P O'Neill, Johnathan A Drevik, Sarah S Christianson, Serge Ginzburg, Andres F Correa, Robert G Uzzo, Eric A Ross, Matthew R Zibelman, Pooja Ghatalia, Elizabeth R Plimack, Alexander Kutikov, Philip H Abbosh
Urine Biopsy as Dynamic Biomarker to Enhance Clinical Staging of Bladder Cancer in Radical Cystectomy Candidates. JCO precision oncology 8 (2024)
Ruben Raychaudhuri, George Mo, Abuzar Moradi Tuchayi, Laura S Graham, Roman Gulati, Colin C Pritchard, Michael C Haffner, Todd Yezefski, Jessica E Hawley, Heather H Cheng, Evan Y Yu, Petros D Grivas, Robert B Montgomery, Peter S Nelson, Delphine L Chen, Thomas A Hope, Amir Iravani, Michael Thomas Schweizer
Genomic Correlates of Prostate-Specific Membrane Antigen Expression and Response to 177 Lu-PSMA-617: A Retrospective Multicenter Cohort Study. JCO precision oncology 8 (2024)
Petros D Grivas, Damien Pouessel, Chandler H Park, Philippe Barthelemy, Manojkumar Bupathi, Daniel P Petrylak, Archana M Agarwal, Sumati V Gupta, Aude Fléchon, Chethan Ramamurthy, Nancy B Davis, Alejandro Recio-Boiles, Cora N Sternberg, Astha Bhatia, Cabilia Pichardo, Mitch Sierecki, Julia Tonelli, Huafeng Zhou, Scott T Tagawa, Yohann Loriot
Sacituzumab Govitecan in Combination With Pembrolizumab for Patients With Metastatic Urothelial Cancer That Progressed After Platinum-Based Chemotherapy: TROPHY-U-01 Cohort 3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Jacob B Leary, Thomas Enright, Dimitra Rafailia Bakaloudi, Alina Basnet, Gennady Bratslavsky, Joseph Jacob, Philippe E Spiess, Roger Li, Andrea Necchi, Ashish M Kamat, Dean C Pavlick, Natalie Danziger, Richard S P Huang, Douglas I Lin, Liang Cheng, Jeffrey Ross, Rafee Talukder, Petros D Grivas
Frequency and Nature of Genomic Alterations in ERBB2-Altered Urothelial Bladder Cancer. Targeted oncology (2024)
Petros D Grivas, Elena Garralda, Funda Meric-Bernstam, Ingo K Mellinghoff, Lipika Goyal, James J Harding, Elizabeth C Dees, Rastislav Bahleda, Nilofer S Azad, Asha Karippot, Razelle Kurzrock, Josep Tabernero, Juha Kononen, Matthew Chau Hsien Ng, Rutika Mehta, Nataliya V Uboha, Frédéric Bigot, Valentina Boni, Samantha E Bowyer, Valeriy Breder, Andres Cervantes, Nancy Chan, James M Cleary, Mallika Dhawan, Rikke Helene Løvendahl Eefsen, James Ewing, Donna M Graham, Tormod Kyrre Guren, Jin Won Kim, Krassimir Koynov, Do Youn Oh, Rebecca A Redman, Chia-Jui Yen, David B Spetzler, Marie-Claude Roubaudi-Fraschini, Valérie Nicolas, Rafik Ait-Sarkouh, Claudio Zanna, Abdallah Ennaji, Anna Pokorska-Bocci, Keith T Flaherty
Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Yohann Loriot, Arjun V Balar, Daniel P Petrylak, Arash Rezazadeh Kalebasty, Petros D Grivas, Aude Flechon, Rohit K Jain, Umang Swami, Manojkumar Bupathi, Philippe Barthélémy, Philippe Beuzeboc, Phillip L Palmbos, Christos E Kyriakopoulos, Damien Pouessel, Cora N Sternberg, Julia Tonelli, Mitch Sierecki, Marianna Zavodovskaya, Emon Elboudwarej, Lauri Diehl, Juliane M Jürgensmeier, Scott T Tagawa
Sacituzumab Govitecan Demonstrates Efficacy across Tumor Trop-2 Expression Levels in Patients with Advanced Urothelial Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Caitriona Cahir, Xin Victoria Wang, David M Hyman, Petros D Grivas, Edith P Mitchell, John J Wright, Elad Sharon, Robert C Gray, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Jue Wang, Kari B Wisinski, James V Tricoli, Barbara A Conley, Lyndsay N Harris, Carlos L Arteaga, Peter J O'Dwyer, Helen X Chen, Keith T Flaherty
Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Daniel P Petrylak, Scott T Tagawa, Rohit K Jain, Manojkumar Bupathi, Arjun V Balar, Arash Rezazadeh Kalebasty, Saby George, Phillip Palmbos, Luke Nordquist, Nancy B Davis, Chethan Ramamurthy, Cora N Sternberg, Yohann Loriot, Archana M Agarwal, Chandler Park, Julia Tonelli, Morganna Vance, Huafeng Zhou, Petros D Grivas
TROPHY-U-01 Cohort 2: A Phase II Study of Sacituzumab Govitecan in Cisplatin-Ineligible Patients With Metastatic Urothelial Cancer Progressing After Previous Checkpoint Inhibitor Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Petros D Grivas, Damien Pouessel, Chandler H Park, Philippe Barthelemy, Manojkumar Bupathi, Daniel P Petrylak, Archana M Agarwal, Sumati V Gupta, Aude Fléchon, Chethan Ramamurthy, Nancy B Davis, Alejandro Recio-Boiles, Cora N Sternberg, Astha Bhatia, Cabilia Pichardo, Mitch Sierecki, Julia Tonelli, Huafeng Zhou, Scott T Tagawa, Yohann Loriot
Sacituzumab Govitecan in Combination With Pembrolizumab for Patients With Metastatic Urothelial Cancer That Progressed After Platinum-Based Chemotherapy: TROPHY-U-01 Cohort 3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Ruben Raychaudhuri, George Mo, Abuzar Moradi Tuchayi, Laura S Graham, Roman Gulati, Colin C Pritchard, Michael C Haffner, Todd Yezefski, Jessica E Hawley, Heather H Cheng, Evan Y Yu, Petros D Grivas, Robert B Montgomery, Peter S Nelson, Delphine L Chen, Thomas A Hope, Amir Iravani, Michael Thomas Schweizer
Genomic Correlates of Prostate-Specific Membrane Antigen Expression and Response to 177 Lu-PSMA-617: A Retrospective Multicenter Cohort Study. JCO precision oncology 8 (2024)
Caitriona Cahir, Xin Victoria Wang, David M Hyman, Petros D Grivas, Edith P Mitchell, John J Wright, Elad Sharon, Robert C Gray, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Jue Wang, Kari B Wisinski, James V Tricoli, Barbara A Conley, Lyndsay N Harris, Carlos L Arteaga, Peter J O'Dwyer, Helen X Chen, Keith T Flaherty
Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Caitriona Cahir, Xin Victoria Wang, David M Hyman, Petros D Grivas, Edith P Mitchell, John J Wright, Elad Sharon, Robert C Gray, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Jue Wang, Kari B Wisinski, James V Tricoli, Barbara A Conley, Lyndsay N Harris, Carlos L Arteaga, Peter J O'Dwyer, Helen X Chen, Keith T Flaherty
Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Petros D Grivas, Damien Pouessel, Chandler H Park, Philippe Barthelemy, Manojkumar Bupathi, Daniel P Petrylak, Archana M Agarwal, Sumati V Gupta, Aude Fléchon, Chethan Ramamurthy, Nancy B Davis, Alejandro Recio-Boiles, Cora N Sternberg, Astha Bhatia, Cabilia Pichardo, Mitch Sierecki, Julia Tonelli, Huafeng Zhou, Scott T Tagawa, Yohann Loriot
Sacituzumab Govitecan in Combination With Pembrolizumab for Patients With Metastatic Urothelial Cancer That Progressed After Platinum-Based Chemotherapy: TROPHY-U-01 Cohort 3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Faisal Fa'ak, Maryam Buni, Adewunmi Falohun, Huifang Lu, Juhee Song, Daniel H Johnson, Chrystia M Zobniw, Van A Trinh, Muhammad Osama Awiwi, Nourel Hoda Tahon, Khaled M Elsayes, Kaysia Ludford, Emma J Montazari, Julia Chernis, Maya Dimitrova, Sabina Sandigursky, Jeffrey A Sparks, Osama Abu-Shawer, Osama Rahma, Uma Thanarajasingam, Ashley M Zeman, Rafee Talukder, Namrata Singh, Sarah H Chung, Petros D Grivas, May Daher, Ala Abudayyeh, Iman Osman, Jeffrey S Weber, Jean H Tayar, Maria E Suarez-Almazor, Noha Abdel-Wahab, Adi Diab
Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events. Journal for immunotherapy of cancer 11 (6) (2023)
Heather H Cheng, Alexandra O Sokolova, Roman Gulati, Deborah Bowen, Sarah A Knerr, Nola Klemfuss, Petros D Grivas, Andrew C Hsieh, John K Lee, Michael Thomas Schweizer, Todd Yezefski, Alicia Y Zhou, Evan Y Yu, Peter S Nelson, Robert B Montgomery
Internet-Based Germline Genetic Testing for Men With Metastatic Prostate Cancer. JCO precision oncology 7 (2023)
Ashish M Kamat, Andrea B Apolo, Marek Babjuk, Trinity J Bivalacqua, Peter C Black, Roger Buckley, Matthew T Campbell, Eva Compérat, Jason Alexander Efstathiou, Petros D Grivas, Shilpa Gupta, Neil J Kurtz, Donald Lamm, Seth P Lerner, Roger Li, David J McConkey, Joan Palou Redorta, Thomas Powles, Sarah P Psutka, Neal D Shore, Gary D Steinberg, Richard Sylvester, J Alfred Witjes, Matthew D Galsky
Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Society for Immunotherapy of Cancer and the International Bladder Cancer Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Funda Meric-Bernstam, James M Ford, Peter J O'Dwyer, Geoffrey I Shapiro, Lisa Meier McShane, Boris Freidlin, Roisin E O'Cearbhaill, Suzanne George, Julia L Glade Bender, Gary H Lyman, James V Tricoli, David R Patton, Stanley R Hamilton, Robert C Gray, Douglas S Hawkins, Bhanumati Ramineni, Keith T Flaherty, Petros D Grivas, Timothy Anthony Yap, Jordan D Berlin, James H Doroshow, Lyndsay N Harris, Jeffrey A Moscow
National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH). Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Heather H Cheng, Alexandra O Sokolova, Roman Gulati, Deborah Bowen, Sarah A Knerr, Nola Klemfuss, Petros D Grivas, Andrew C Hsieh, John K Lee, Michael Thomas Schweizer, Todd Yezefski, Alicia Y Zhou, Evan Y Yu, Peter S Nelson, Robert B Montgomery
Internet-Based Germline Genetic Testing for Men With Metastatic Prostate Cancer. JCO precision oncology 7 (2023)
Thomas Powles, Se Hoon Park, Claudia Caserta, Begoña P Valderrama, Howard Gurney, Anders Ullén, Yohann Loriot, Srikala S Sridhar, Cora N Sternberg, Joaquim Bellmunt, Jeanny B Aragon-Ching, Jing Wang, Bo Huang, Robert J Laliberte, Alessandra di Pietro, Petros D Grivas
Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-Up. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Heather H Cheng, Alexandra O Sokolova, Roman Gulati, Deborah Bowen, Sarah A Knerr, Nola Klemfuss, Petros D Grivas, Andrew C Hsieh, John K Lee, Michael Thomas Schweizer, Todd Yezefski, Alicia Y Zhou, Evan Y Yu, Peter S Nelson, Robert B Montgomery
Internet-Based Germline Genetic Testing for Men With Metastatic Prostate Cancer. JCO precision oncology 7 (2023)
Heather H Cheng, Alexandra O Sokolova, Roman Gulati, Deborah Bowen, Sarah A Knerr, Nola Klemfuss, Petros D Grivas, Andrew C Hsieh, John K Lee, Michael Thomas Schweizer, Todd Yezefski, Alicia Y Zhou, Evan Y Yu, Peter S Nelson, Robert B Montgomery
Internet-Based Germline Genetic Testing for Men With Metastatic Prostate Cancer. JCO precision oncology 7 (2023)
Funda Meric-Bernstam, James M Ford, Peter J O'Dwyer, Geoffrey I Shapiro, Lisa Meier McShane, Boris Freidlin, Roisin E O'Cearbhaill, Suzanne George, Julia L Glade Bender, Gary H Lyman, James V Tricoli, David R Patton, Stanley R Hamilton, Robert C Gray, Douglas S Hawkins, Bhanumati Ramineni, Keith T Flaherty, Petros D Grivas, Timothy Anthony Yap, Jordan D Berlin, James H Doroshow, Lyndsay N Harris, Jeffrey A Moscow
National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH). Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Heather H Cheng, Alexandra O Sokolova, Roman Gulati, Deborah Bowen, Sarah A Knerr, Nola Klemfuss, Petros D Grivas, Andrew C Hsieh, John K Lee, Michael Thomas Schweizer, Todd Yezefski, Alicia Y Zhou, Evan Y Yu, Peter S Nelson, Robert B Montgomery
Internet-Based Germline Genetic Testing for Men With Metastatic Prostate Cancer. JCO precision oncology 7 (2023)
Heather H Cheng, Alexandra O Sokolova, Roman Gulati, Deborah Bowen, Sarah A Knerr, Nola Klemfuss, Petros D Grivas, Andrew C Hsieh, John K Lee, Michael Thomas Schweizer, Todd Yezefski, Alicia Y Zhou, Evan Y Yu, Peter S Nelson, Robert B Montgomery
Internet-Based Germline Genetic Testing for Men With Metastatic Prostate Cancer. JCO precision oncology 7 (2023)
Jianya Huan, Petros D Grivas, Jasmine Birch, Donna E Hansel
Emerging Roles for Mammalian Target of Rapamycin (mTOR) Complexes in Bladder Cancer Progression and Therapy. Cancers 14 (6) (2022)
Michael J Wagner, Cassandra Hennessy, Alicia Beeghly, Benjamin French, Dimpy P Shah, Sarah Croessmann, Diana Vilar Compte, Erika Ruiz-Garcia, Matthew Ingham, Gary K Schwartz, Corrie A Painter, Rashmi Chugh, Leslie Fecher, Cathleen Park, Olga Zamulko, Jonathan C Trent, Vivek Subbiah, Ali Raza Khaki, Lisa Tachiki, Elizabeth S Nakasone, Elizabeth T Loggers, Chris Labaki, Renee Maria Saliby, Rana R McKay, Archana Ajmera, Elizabeth A Griffiths, Igor Puzanov, William D Tap, Clara Hwang, Sheela Tejwani, Sachin M Jhawar, Brandon Hayes-Lattin, Elizabeth Marie Wulff-Burchfield, Anup Kasi, Daniel Y Reuben, Gayathri Nagaraj, Monika D Joshi, Hyma Polimera, Amit A Kulkarni, Khashayar Esfahani, Daniel H Kwon, Luca Paoluzzi, Mehmet A Bilen, Eric B Durbin, Petros D Grivas, Jeremy L Warner, Elizabeth J Davis, null null
Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study. Cancers 14 (17) (2022)
Laura C Kennedy, Jun Lu, Sydney Kuehn, Arturo B Ramirez, Edward Lo, Yao Sun, Lance U'Ren, Laura Q M Chow, Zhengjia Chen, Petros D Grivas, Eric P Kaldjian, Vijayakrishna K Gadi
Liquid Biopsy Assessment of Circulating Tumor Cell PD-L1 and IRF-1 Expression in Patients with Advanced Solid Tumors Receiving Immune Checkpoint Inhibitor. Targeted oncology 17 (3) (2022)
Razvan Cristescu, Michael Nebozhyn, Chunsheng Zhang, Andrew Albright, Julie Kobie, Lingkang Huang, Qing Zhao, Anran Wang, Hua Ma, Z Alexander Cao, Michael Morrissey, Antoni Ribas, Petros D Grivas, David W Cescon, Terrill K McClanahan, Alexandra Snyder, Mark Ayers, Jared Lunceford, Andrey Loboda
Transcriptomic Determinants of Response to Pembrolizumab Monotherapy across Solid Tumor Types. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (8) (2022)
Joaquim Bellmunt, Ronald de Wit, Yves Fradet, Miguel A Climent, Daniel P Petrylak, Jae Lyun Lee, Lawrence Fong, Andrea Necchi, Cora N Sternberg, Peter H O'Donnell, Thomas Powles, Elizabeth R Plimack, Dean F Bajorin, Arjun V Balar, Daniel Castellano, Toni K Choueiri, Stephane Culine, Winald R Gerritsen, Howard Gurney, David I Quinn, Jacqueline Vuky, Nicholas J Vogelzang, Razvan Cristescu, Jared Lunceford, Assieh Saadatpour, Andrey Loboda, Junshui Ma, Mohini Rajasagi, James Luke Godwin, Blanca Homet Moreno, Petros D Grivas
Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (10) (2022)
Daniel S Carlson, Petros D Grivas, Wei Wei, Puneet K Dhillon, Samir Abraksia
The Effectiveness of Shared Compared to Informed Decision Making for Prostate Cancer Screening in a High-Risk African American Population: A Randomized Control Trial. Cancer investigation 39 (2) (2021)
Vadim S Koshkin, Nicholas Henderson, Marihella James, Divya Natesan, Dory Freeman, Amanda Nizam, Christopher T Su, Ali Raza Khaki, Chelsea K Osterman, Michael J Glover, Ryan Chiang, Dimitrios Makrakis, Rafee Talukder, Emily Lemke, T Anders Olsen, Jayanshu Jain, Albert Jang, Alicia Ali, Tanya Jindal, Jonathan Chou, Terence W Friedlander, Christopher Hoimes, Arnab Basu, Yousef Zakharia, Pedro C Barata, Mehmet A Bilen, Hamid Emamekhoo, Nancy B Davis, Sumit A Shah, Matthew I Milowsky, Shilpa Gupta, Matthew T Campbell, Petros D Grivas, Guru P Sonpavde, Deepak Kilari, Ajjai S Alva
Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study. Cancer (2021)
Scott T Tagawa, Arjun V Balar, Daniel P Petrylak, Arash Rezazadeh Kalebasty, Yohann Loriot, Aude Fléchon, Rohit K Jain, Archana M Agarwal, Manojkumar Bupathi, Philippe Barthelemy, Philippe Beuzeboc, Phillip Palmbos, Christos E Kyriakopoulos, Damien Pouessel, Cora N Sternberg, Quan Hong, Trishna Goswami, Loretta M Itri, Petros D Grivas
TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (22) (2021)
Ali Raza Khaki, Shasank Chennupati, Catherine R Fedorenko, Lily Li, Qin Sun, Petros D Grivas, Scott D Ramsey, Stephen M Schwartz, Veena Shankaran
Utilization of Systemic Therapy in Patients With Cancer Near the End of Life in the Pre- Versus Postimmune Checkpoint Inhibitor Eras. JCO oncology practice 17 (11) (2021)
Scott T Tagawa, Petros D Grivas
Reply to T. Powles et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (30) (2021)
Thomas Powles, Srikala S Sridhar, Yohann Loriot, Joaquim Bellmunt, Xinmeng Jasmine Mu, Keith A Ching, Jie Pu, Cora N Sternberg, Daniel P Petrylak, Rosa Tambaro, Louis M Dourthe, Carlos Alvarez-Fernandez, Maureen Aarts, Alessandra di Pietro, Petros D Grivas, Craig B Davis
Avelumab maintenance in advanced urothelial carcinoma: biomarker analysis of the phase 3 JAVELIN Bladder 100 trial. Nature medicine (2021)
Petros D Grivas, Y Loriot, R Morales-Barrera, M Y Teo, Y Zakharia, S Feyerabend, N J Vogelzang, E Grande, N Adra, A Alva, A Necchi, A Rodriguez-Vida, S Gupta, D H Josephs, S Srinivas, K Wride, D Thomas, A Simmons, A Loehr, R L Dusek, D Nepert, S Chowdhury
Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS). BMC cancer 21 (1) (2021)
Andrea Necchi, Vito Cucchiara, Petros D Grivas, Gennady Bratslavsky, Joseph Jacob, Philippe E Spiess, Ethan S Sokol, Jonathan Keith Killian, Douglas Lin, Shakti Ramkissoon, Richard S P Huang, Russell W Madison, Jeffrey M Venstrom, Alexa B Schrock, Natalie Danziger, Brennan Decker, Ole Gjoerup, Ryon P Graf, Geoffrey R Oxnard, Hanna Tukachinsky, Jeffrey S Ross
Contrasting genomic profiles from metastatic sites, primary tumors, and liquid biopsies of advanced prostate cancer. Cancer 127 (24) (2021)
Ali Raza Khaki, Neeraj Agarwal, Sumanta Kumar Pal, Petros D Grivas
Immunotherapy-based combination strategies for advanced urothelial cancer: A long quest. Cancer 126 (20) (2020)
Alexios-Fotios A Mentis, Petros D Grivas, Efthimios Dardiotis, Nicholas A Romas, Donatella Delle Cave
Circulating tumor cells as Trojan Horse for understanding, preventing, and treating cancer: a critical appraisal. Cellular and molecular life sciences : CMLS 77 (18) (2020)
Donna R Rivera, Solange Peters, Orestis A Panagiotou, Dimpy P Shah, Nicole M Kuderer, Chih-Yuan Hsu, Samuel M Rubinstein, Brendan J Lee, Toni K Choueiri, Gilberto de Lima Lopes, Petros D Grivas, Corrie A Painter, Brian I Rini, Michael A Thompson, Jonathan Arcobello, Ziad Bakouny, Deborah B Doroshow, Pamela C Egan, Dimitrios Farmakiotis, Leslie A Fecher, Christopher R Friese, Matthew D Galsky, Sanjay Goel, Shilpa Gupta, Thorvardur R Halfdanarson, Balazs Halmos, Jessica E Hawley, Ali Raza Khaki, Christopher A Lemmon, Sanjay Mishra, Adam J Olszewski, Nathan A Pennell, Matthew M Puc, Sanjay G Revankar, Lidia Schapira, Andrew Schmidt, Gary K Schwartz, Sumit A Shah, Julie Tsu-Yu Wu, Zhuoer Xie, Albert C Yeh, Huili Zhu, Yu Shyr, Gary H Lyman, Jeremy L Warner, null null
Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study. Cancer discovery 10 (10) (2020)
Petros D Grivas, Bradley J Monk, Daniel Petrylak, Martin Reck, Grace Foley, Silke Guenther, Dan Hennessy, Constantin Makris, Markus Moehler
Immune Checkpoint Inhibitors as Switch or Continuation Maintenance Therapy in Solid Tumors: Rationale and Current State. Targeted oncology 14 (5) (2020)
Alice Tzeng, C Marcela Diaz-Montero, Patricia A Rayman, Jin S Kim, Paul G Pavicic, James H Finke, Pedro C Barata, Marcelo Lamenza, Sarah Devonshire, Kim Schach, Hamid Emamekhoo, Marc S Ernstoff, Christopher J Hoimes, Brian I Rini, Jorge A Garcia, Timothy D Gilligan, Moshe C Ornstein, Petros D Grivas
Immunological Correlates of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma. Targeted oncology 13 (5) (2019)
Ali Raza Khaki, Ang Li, Leonidas N Diamantopoulos, Mehmet Asim Bilen, Victor Santos, John Esther, Rafael Morales-Barrera, Michael Devitt, Ariel Nelson, Christopher J Hoimes, Evan Shreck, Hussein A Assi, Benjamin A Gartrell, Alex Sankin, Alejo Rodriguez-Vida, Mark Lythgoe, David James Pinato, Alexandra Drakaki, Monika Joshi, Pedro Isaacsson Velho, Noah Hahn, Sandy Liu, Lucia Alonso Buznego, Ignacio Duran, Marcus Moses, Jayanshu Jain, Jure Murgic, Praneeth Baratam, Pedro Barata, Abhishek Tripathi, Yousef Zakharia, Matthew D Galsky, Guru Sonpavde, Evan Y Yu, Veena Shankaran, Gary H Lyman, Petros D Grivas
Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with immune checkpoint inhibitors. Cancer 126 (6) (2019)
Umang Swami, Petros D Grivas, Archana M Agarwal
The Quest for an Ideal Neoadjuvant Systemic Therapy in Cisplatin-Ineligible Patients with Muscle-Invasive Localized Urothelial Carcinoma. The oncologist 24 (5) (2019)
Monica Khunger, Sagar Rakshit, Adrian V Hernandez, Vinay Pasupuleti, Kate Glass, Matthew D Galsky, Petros D Grivas
Premature Clinical Trial Discontinuation in the Era of Immune Checkpoint Inhibitors. The oncologist 23 (12) (2018)